Health Canada has acknowledged a link between AstraZeneca’s COVID-19 vaccine and “extremely rare” blood clots, but says the benefits of using the vaccine still outweigh its risks. Sharma put the risk of those blood clots — which have been associated with low levels of blood platelets — in context. For adult women under the age of 45, she said, the risk of a blood clot is about one in 3,300. By comparison, Sharma said the risk of a blood clot caused by AstraZeneca is approximately one in 250,000. Loading... Loading... Loading... Loading... Loading... Loading...On Tuesday, the United States paused its use of a COVID-19 vaccine produced by Johnson & Johnson following reports that six women experienced blood clots after getting the shot.

Source: thestar April 14, 2021 15:34 UTC